mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.3 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.3 |